Ganoderma for Diabetes

Ganoderma for Diabetes
The fourth herb is Ganoderma Lucidum. This herb helps to boost body energy and improve blood circulation. Therefore, Ganoderma Lucidum is one of the important herbs for diabetes.

Although Ganoderma Lucidum herb alone is not enough, it can help to improve your blood circulation and increase their immune system. This prevents the disease from worsening.

The polysaccharides found in Ganoderma and Cordyceps are also proved to help insulin to transfer sugar into body cells.

The requirement
Before this, please take note of the following:

1) Reduce sugar and sweet food intake
2) Don't get angry and stressful
3) Exercise regularly


ABSTRACT:

Animal studies have demonstrated that the polysaccharide fractions of Ganoderma lucidum (Ling Zhi, reishi mushroom) have potential hypoglycemic and hypolipidemic activities. This clinical study aimed to evaluate the efficacy and safety of Ganopoly (polysaccharide fractions extracted from G. lucidum by patented technique) in 71 patients with confirmed type II diabetes mellitus (DM). Eligibility criteria included type II DM of >3 months' duration for which patients were not receiving insulin; age >18 years; normal vital signs for age and disease state; normal electrocardiogram (ECG); and fasting plasma glucose (FPG) level of 8.9.16.7 mmol/L in sulfonylurea-naive patients or an FPG <10 mmol/L before washout in sulfonylurea-treated patients. Patients were randomly grouped to be given either Ganopoly or placebo orally at 1800 mg three times daily for 12 weeks. Patients underwent 4 weeks of dose adjustment followed by 8 weeks of dose maintenance. Fasting and stimulated glycosylated hemoglobin (HbA1c), plasma glucose, insulin, and C-peptide were monitered at predetermined intervals. Adverse events and hypoglycemic episodes were recorded. The treatment of Ganopoly significantly decreased the mean HbA1c from 8.4 at baseline to 7.6% at 12 weeks. Significant changes in mean FPG and PPG levels at the last visit paralleled the changes in mean HbA1c levels. At baseline, the mean FPG and PPG values in patients treated with Ganopoly were 12.0 and 13.6 mmol/L, respectively. At week 12, mean PPG values had decreased to 11.8 mmol/L. However, these parameters did not change or slightly increased in patients receiving placebo. The between-group difference in PPG levels at week 12 was significant (p < 0.05). Changes in fasting insulin, 2-hour post-prandial insulin, fasting C-peptide, and 2-hour post-prandial C-peptide were consistent, with the between-group differences in these end points being significant at the last visit. Overall, Ganopoly was well tolerated. This study demonstrated that Ganopoly was efficacious and safe in lowering blood glucose concentrations.


"Chinese herb Ganoderma lucidum mushroom can reversed diabetes"

A team from the University of Western Sydney’s Centre for Complementary Medicine Research (CompleMED) is working with the Cardiac Health Institute to find out if the medicinal mushroom, Ganoderma lucidum, can reduce high blood sugar, often a precursor to diabetes - as well as treat other health problems.
The clinical trial is the first of its kind to rigorously test the mushroom - known in Asia as the ‘King of herbs’, because of its huge range of medicinal properties - and needs 170 Sydneysiders to take part.

UWS PhD researcher Nerida Klupp hopes the findings contribute to western medicine’s knowledge of this Chinese herb, and provide much-needed clinical evidence of a possible new treatment for people with metabolic syndrome.

“Many people in Australia have high blood sugar, which is often classified as diabetes or pre-diabetes. Many also have other medical problems such as high blood pressure, obesity and high cholesterol,” she says.

“Scientists and doctors now know these conditions are linked, and a person with at least three of these health problems is diagnosed with a condition called metabolic syndrome - also called ‘Syndrome X’.”

“Affluent countries with lazy lifestyles and bad diets are at particular risk, with 44 per cent of Americans aged over 50 years of age diagnosed with metabolic syndrome. While we don’t really know how prevalent the condition is here in Australia, we suspect similar trends to those in the United States,” Ms Klupp says.

“Currently there is no single pharmaceutical treatment for metabolic syndrome, which is why we are conducting the first randomised clinical trial to test if this medicinal mushroom can offer western medicine an effective, long-term treatment to help lower blood sugar as well as control other problems associated with the condition,” he says.

Nerida Klupp says the mushroom has been revered in Asia for over 2000 years.

“Ganoderma lucidum, which is also known as Reishi, has long been used to fight a wide range of diseases, and was thought to be the ‘elixir of immortality’ - enhancing vitality and helping to delay ageing,” she says.

Thankfully, there has been increased cultivation of the herb over the last thirty years, and preliminary animal and human pilot studies have proved promising, suggesting it can have a positive effect on blood sugar levels, cholesterol levels and blood fats.

Traditionally, Ganoderma lucidum has been considered to be even more potent when taken in combination with another medicinal mushroom called Cordyceps sinensis.

“Cordyceps is also thought to have significant health properties, so we want to find out if Ganoderma is effective on its own, or whether it works better in combination with the second mushroom,” says Ms Klupp.